The purpose of this study was to demonstrate that living bone allotransplants can incorporate, remodel, and maintain mechanical properties without long-term immunosuppression in a fashion comparable to living autotransplants. For this, viability is maintained by repair of nutrient vessels and neovascularization from implanted host-derived vasculature. Microsurgically revascularized femoral diaphysis allotransplants were transferred from young male New-Zealand-White (NZW) into 4 groups of male Dutch-Belted (DB) rabbits. Short-term immunosuppression by tacrolimus (IS, groups 4 and 5) and host-derived neovascularization (NV) from implanted fascial flaps was used to maintain viability (groups 3 and 5) as independent variables. Group 2 received neither IS nor NV. Vascularized pedicled autotransplants were orthotopically transplanted in group 1. After 16 weeks, transplants were evaluated using radiologic, histologic, biomechanical, and histomorphometric parameters. Vascularized bone allotransplants treated with both short-term IS and host-derived NV (group 5) healed in a fashion similar to pedicled autotransplants (group 1). Their radiographic scores were higher than other groups. Groups with patent fascial flaps (3 and 5) showed significantly greater neoangiogenesis than ligated controls (2 and 4). Tacrolimus administration did not affect neoangiogenesis. Elastic modulus and ultimate stress were significantly greater in autogenous bone than in allotransplanted femora. Biomechanical properties were not significantly different among allotransplants. Bone turnover was decreased with IS, but increased with NV by the implanted fascial flaps. Living allogeneic femoral allotransplants treated with short-term IS and host-derived neoangiogenesis can lead to stable transplant incorporation in this rabbit model. The reconstruction of skeletal defects remains a challenging reconstructive problem, for which vascularized bone autotransplants are among the best options. They heal more reliably and quickly, remodel more effectively, and resist infection better than nonviable allografts. 1 Limited donor sites, potential donor site morbidity, and poor geometric matching to defects create surgical challenges. 2 Prosthetic replacement and distraction osteogenesis also have significant rates of hardware failure or sepsis. 2 Avascular structural bone allografts do not fully incorporate and demonstrate little remodeling.Living bone allotransplantation is intriguing, given absence of donor morbidity, close geometric matching, and potentially similar healing/remodeling to living autotransplant bone. A few reports of clinical use, however, have demonstrated poor viability and mechanical properties, and problems with infections. [3][4][5] The need to maintain long-term immunosuppression (IS) raises concerns for potential severe side-effects, which are difficult to justify for extremity-preserving procedures.We previously have described a method of living allogeneic bone transplantation in the rat not requiring long-term IS, made poss...